Alagille syndrome natural history: Difference between revisions
Jump to navigation
Jump to search
m (Robot: Changing Category:Mature chapter to Category:Overview complete) |
|||
| Line 11: | Line 11: | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
{{WH}} | |||
{{WS}} | |||
[[Category:Pediatrics]] | [[Category:Pediatrics]] | ||
| Line 17: | Line 19: | ||
[[Category:Rare diseases]] | [[Category:Rare diseases]] | ||
[[Category:Hepatology]] | [[Category:Hepatology]] | ||
[[Category: | [[Category:Overview complete]] | ||
Revision as of 18:30, 17 April 2012
|
Alagille syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Alagille syndrome natural history On the Web |
|
American Roentgen Ray Society Images of Alagille syndrome natural history |
|
Risk calculators and risk factors for Alagille syndrome natural history |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
The prognosis for Alagille syndrome patients varies largely on choice of treatment.
Prognosis
Mortality is approximately 10%, with vascular accidents, cardiac disease, and liver disease accounting for most of the deaths. Vascular anomalies account for 34% of the mortality in this population [1].
References
- ↑ Kamath BM, Spinner NB, Emerick KM, Chudley AE, Booth C, Piccoli DA; et al. (2004). "Vascular anomalies in Alagille syndrome: a significant cause of morbidity and mortality". Circulation. 109 (11): 1354–8. doi:10.1161/01.CIR.0000121361.01862.A4. PMID 14993126.